Skip to content

Babesia Testing in Blood Donors

Blood Donation Screening for Babesia Microti by Real-time Polymerase Chain Reaction (PCR) and by Indirect Flourescent Antibody (IFA) Assays

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01528449
Enrollment
90116
Registered
2012-02-08
Start date
2011-12-31
Completion date
2014-09-30
Last updated
2017-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transfusion Transmitted Babesiosis

Keywords

babesia, blood donation, transfusion transmitted babesiosis

Brief summary

Both prospective and retrospective (look back) study of blood donors for laboratory evidence of babesia microti infection. Two laboratory methodologies will be utilized: 1. \- PCR, to look for the presence of B.microti in whole blood 2. \- IFA, to look for significant titers of B.microti antibody

Detailed description

Retrospective study will involve archived specimens from blood donors whose units have already been released and transfused into recipients. Prospective study will be real time and units testing positive by either PCR or IFA will be not released and will be disgarded, and the donors advised and deferred from further blood donation

Interventions

BIOLOGICALB.microti diagnostic blood tests

the interventions/procedures are investigational diagnostic tests for B.microti (PCR and IFA).

Sponsors

American National Red Cross
CollaboratorOTHER
Memorial Blood Centers, Minnesota
CollaboratorOTHER
Rhode Island Blood Center
CollaboratorUNKNOWN
Imugen
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* same as for donating blood

Exclusion criteria

* donor refusual to sign informed consent for this investigational babesia testing

Design outcomes

Primary

MeasureTime frame
number of blood donors testing positive for evidence of Babesia infectiongoal is up to one year (all specimens by end 2012)

Secondary

MeasureTime frame
the number of cases of transfusion transmitted babesia infection identifiedgoal is up to one year (all specimens by end 2012)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026